bioMérieux S.A. (BMXMF)
USD 103.09
(0.0%)
USD 103.09
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 357.6 Million EUR | -20.95% |
| 2022 | 452.4 Million EUR | -24.74% |
| 2021 | 601.1 Million EUR | 48.64% |
| 2020 | 404.4 Million EUR | 48.24% |
| 2019 | 272.8 Million EUR | 6.35% |
| 2018 | 256.5 Million EUR | 7.73% |
| 2017 | 238.1 Million EUR | 32.94% |
| 2016 | 179.1 Million EUR | 62.08% |
| 2015 | 110.5 Million EUR | -18.09% |
| 2014 | 134.9 Million EUR | -17.89% |
| 2013 | 164.3 Million EUR | 22.25% |
| 2012 | 134.4 Million EUR | -15.04% |
| 2011 | 158.2 Million EUR | -0.32% |
| 2010 | 158.7 Million EUR | 7.37% |
| 2009 | 147.8 Million EUR | 13.78% |
| 2008 | 129.9 Million EUR | 32.55% |
| 2007 | 98 Million EUR | -6.93% |
| 2006 | 105.3 Million EUR | 16.87% |
| 2005 | 90.1 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 215.3 Million EUR | 9.85% |
| 2023 Q4 | 196 Million EUR | 21.29% |
| 2023 FY | 357.6 Million EUR | -20.95% |
| 2023 Q2 | 161.6 Million EUR | -27.95% |
| 2022 FY | 452.4 Million EUR | -24.74% |
| 2022 Q2 | 228 Million EUR | -29.63% |
| 2022 Q4 | 224.3 Million EUR | -1.62% |
| 2021 Q4 | 324 Million EUR | 16.93% |
| 2021 FY | 601.1 Million EUR | 48.64% |
| 2021 Q2 | 277.1 Million EUR | 19.7% |
| 2020 Q4 | 231.5 Million EUR | 33.89% |
| 2020 FY | 404.4 Million EUR | 48.24% |
| 2020 Q2 | 172.9 Million EUR | 30.69% |
| 2019 Q2 | 140.5 Million EUR | 14.88% |
| 2019 Q4 | 132.3 Million EUR | -5.84% |
| 2019 FY | 272.8 Million EUR | 6.35% |
| 2018 Q2 | 134.19 Million EUR | -2.04% |
| 2018 FY | 256.5 Million EUR | 7.73% |
| 2018 Q4 | 122.3 Million EUR | -8.87% |
| 2017 Q4 | 137 Million EUR | 35.51% |
| 2017 FY | 238.1 Million EUR | 32.94% |
| 2017 Q2 | 101.1 Million EUR | 8.24% |
| 2016 Q4 | 93.4 Million EUR | 8.98% |
| 2016 FY | 179.1 Million EUR | 62.08% |
| 2016 Q2 | 85.7 Million EUR | 68.37% |
| 2015 FY | 110.5 Million EUR | -18.09% |
| 2015 Q4 | 50.9 Million EUR | -14.6% |
| 2015 Q2 | 59.6 Million EUR | -29.47% |
| 2014 Q2 | 50.4 Million EUR | -40.43% |
| 2014 FY | 134.9 Million EUR | -17.89% |
| 2014 Q4 | 84.5 Million EUR | 67.66% |
| 2013 Q4 | 84.6 Million EUR | 6.15% |
| 2013 FY | 164.3 Million EUR | 22.25% |
| 2013 Q2 | 79.7 Million EUR | 0.0% |
| 2012 Q4 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2012 FY | 134.4 Million EUR | -15.04% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | 158.2 Million EUR | -0.32% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 FY | 158.7 Million EUR | 7.37% |
| 2010 Q4 | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 FY | 147.8 Million EUR | 13.78% |
| 2008 FY | 129.9 Million EUR | 32.55% |
| 2007 FY | 98 Million EUR | -6.93% |
| 2006 FY | 105.3 Million EUR | 16.87% |
| 2005 FY | 90.1 Million EUR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.41 Million USD | 25461.702% |
| Arrayit Corporation | -3.31 Million USD | 10885.398% |
| Atlantic International Corp. | -5.62 Million USD | 6454.406% |
| Biocept, Inc. | -32.08 Million USD | 1214.47% |
| Bioqual, Inc. | 483.48 Thousand USD | -73863.61% |
| CardioGenics Holdings Inc | -1.91 Million USD | 18760.728% |
| DermTech, Inc. | -100.88 Million USD | 454.452% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.02 Billion USD | 82.339% |
| HTG Molecular Diagnostics, Inc. | -21.59 Million USD | 1755.979% |
| iMD Companies, Inc. | -200.63 Thousand USD | 178333.218% |
| IDenta Corp. | 14.64 Thousand USD | -2441855.75% |
| Interpace Biosciences, Inc. | 802 Thousand USD | -44488.529% |
| Integrative Health Technologies, Inc. | 38.68 Thousand USD | -924193.727% |
| InVitro International | 1553.00 USD | -23026300.515% |
| Lumos Diagnostics Holdings Limited | -8.59 Million USD | 4262.011% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | 615463.436% |
| Medical Imaging Corp. | -3.02 Million USD | 11929.215% |
| NovelStem International Corp. | -4.18 Million USD | 8640.109% |
| Optigenex Inc. | -2.89 Million USD | 12440.567% |
| PharmChem, Inc. | 845.1 Thousand USD | -42214.419% |
| Proteome Sciences plc | -2.44 Million USD | 14737.74% |
| Response Genetics, Inc | -20.18 Million USD | 1871.7% |
| Rennova Health, Inc. | -3.29 Million USD | 10959.217% |
| RushNet, Inc. | -607.02 Thousand USD | 59009.968% |
| ScreenPro Security Inc. | -2.24 Million USD | 16002.048% |
| Stella Diagnostics Inc. | -5.7 Million USD | 6365.519% |
| StageZero Life Sciences Ltd. | -11.41 Million USD | 3232.618% |
| Todos Medical Ltd. | -24.99 Million USD | 1530.743% |